How to buy BioHiTech Global stock

BioHiTech Global, Inc is a pollution & treatment controls business based in the US. BioHiTech Global shares (BHTG) are listed on the NASDAQ and all prices are listed in US Dollars. BioHiTech Global employs 42 staff and has a trailing 12-month revenue of around 0.00.

BioHiTech Global share price

Use our graph to track the performance of BHTG stocks over time.

BioHiTech Global shares at a glance

• Key figures

Information last updated 2021-04-30.

52-week range	$1.05 - $3.20
50-day moving average	$1.59
200-day moving average	$1.53
Wall St. target price	$5.00
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-0.58

Buy BioHiTech Global shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy BioHiTech Global stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of BioHiTech Global, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

BioHiTech Global financials

Revenue TTM	$5.9 million
Gross profit TTM	$226,403
Return on assets TTM	-11.81%
Return on equity TTM	-258.54%
Profit margin	-196.25%
Book value	$-0.22
Market capitalisation	$42.1 million

TTM: trailing 12 months

Shorting BioHiTech Global shares

There are currently 486,721 BioHiTech Global shares held short by investors – that's known as BioHiTech Global's "short interest". This figure is 19.8% up from 406,305 last month.

There are a few different ways that this level of interest in shorting BioHiTech Global shares can be evaluated.

BioHiTech Global's "short interest ratio" (SIR)

BioHiTech Global's "short interest ratio" (SIR) is the quantity of BioHiTech Global shares currently shorted divided by the average quantity of BioHiTech Global shares traded daily (recently around 2.4 million). BioHiTech Global's SIR currently stands at 0.2. In other words for every 100,000 BioHiTech Global shares traded daily on the market, roughly 200 shares are currently held short.

However BioHiTech Global's short interest can also be evaluated against the total number of BioHiTech Global shares, or, against the total number of tradable BioHiTech Global shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case BioHiTech Global's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 BioHiTech Global shares in existence, roughly 20 shares are currently held short) or 0.0201% of the tradable shares (for every 100,000 tradable BioHiTech Global shares, roughly 20 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against BioHiTech Global.

Find out more about how you can short BioHiTech Global stock.

BioHiTech Global share dividends

We're not expecting BioHiTech Global to pay a dividend over the next 12 months.

BioHiTech Global share price volatility

Over the last 12 months, BioHiTech Global's shares have ranged in value from as little as $1.05 up to $3.2. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while BioHiTech Global's is 1.2907. This would suggest that BioHiTech Global's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

BioHiTech Global overview

BioHiTech Global, Inc. , through its subsidiaries, provides technological, biological, and mechanical engineering solutions of organic and municipal waste worldwide. Its suite of technologies includes on-site biological processing equipment for food waste, patented processing facilities for the conversion of municipal solid waste into renewable fuel, and proprietary real-time data analytics tools to reduce food waste generation. The company also markets Revolution Series Digesters, an aerobic digestion technology solution for the disposal of food waste at the point of generation; and High Efficiency Biological Treatment Resource Recovery Technology to process waste at the municipal or enterprise level. In addition, it offers BioHiTech Cloud and Cirrus mobile applications for digester customers. Its principal customers include producers of food waste. The company serves healthcare, grocery, prison, retail food service, education, and hospitality sectors, as well as food distributors, convention centers, hotels, restaurants, stadiums, municipalities and academic institutions, and stadiums.

Frequently asked questions

• What percentage of BioHiTech Global is owned by insiders or institutions?

  Currently 18.494% of BioHiTech Global shares are held by insiders and 2.043% by institutions.

• How many people work for BioHiTech Global?

  Latest data suggests 42 work at BioHiTech Global.

• When does the fiscal year end for BioHiTech Global?

  BioHiTech Global's fiscal year ends in December.

• Where is BioHiTech Global based?

  BioHiTech Global's address is: 80 Red Schoolhouse Road, Chestnut Ridge, NY, United States, 10977

• What is BioHiTech Global's ISIN number?

  BioHiTech Global's international securities identification number is: US09074B1070

• What is BioHiTech Global's CUSIP number?

  BioHiTech Global's Committee on Uniform Securities Identification Procedures number is: 09074B107